Serum amyloid a in clinical practice
Serum amyloid A (SAA) is an acute phase first class protein discovered a quarter of the century ago. Its concentration depends on clinical findings of the patient, illness activity and the therapy applied. SAA increases moderately to markedly (100-1000 mg/l) in bacterial and fungal infections, invas...
Main Author: | Jovanović Dijana B. |
---|---|
Format: | Article |
Language: | English |
Published: |
Serbian Medical Society
2004-01-01
|
Series: | Srpski Arhiv za Celokupno Lekarstvo |
Subjects: | |
Online Access: | http://www.doiserbia.nb.rs/img/doi/0370-8179/2004/0370-81790408267J.pdf |
Similar Items
-
Relationship between Serum Soluble Interleukin-2 Receptor and Renal Allograft Rejection: A Hospital-Based Study in Kashmir Valley
by: R Rasool, et al.
Published: (2015-01-01) -
Transplantation Tolerance through Hematopoietic Chimerism: Progress and Challenges for Clinical Translation
by: Benedikt Mahr, et al.
Published: (2017-12-01) -
Suppression of Inflammation-Associated Kidney Damage Post-Transplant Using the New PrC-210 Free Radical Scavenger in Rats
by: Torsten R. Goesch, et al.
Published: (2021-07-01) -
Allograft rejection after living-related simple limbal epithelial transplantation
by: Jayesh Vazirani, et al.
Published: (2021-01-01) -
Hand Transplantation: Current concepts and management algorithm
by: Carlos Ivan Carrillo-Moreno, et al.
Published: (2017-07-01)